FIRING UP THE TUMOR MICRO-ENVIRONMENT IN METASTATIC PROSTATE CANCER WITH SYNERGISTIC PSMA-TARGETING RADIOLIGANDS AND STING AGONIST NANO-THERAPIES

The General Hospital Corporation

Investigators